These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 524251

  • 1. Osmotic opening of the blood-brain barrier to methotrexate in the rat.
    Ohno K, Fredericks WR, Rapoport SI.
    Surg Neurol; 1979 Oct; 12(4):323-8. PubMed ID: 524251
    [Abstract] [Full Text] [Related]

  • 2. [3H]Methotrexate loss from the rat brain following enhanced uptake by osmotic opening of the blood-brain barrier.
    Ohata M, Fredericks WR, Neuwelt EA, Sundaram U, Rapoport SI.
    Cancer Res; 1985 Mar; 45(3):1092-6. PubMed ID: 3971363
    [Abstract] [Full Text] [Related]

  • 3. Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat.
    Greig NH, Fredericks WR, Holloway HW, Soncrant TT, Rapoport SI.
    J Pharmacol Exp Ther; 1988 May; 245(2):581-6. PubMed ID: 3367308
    [Abstract] [Full Text] [Related]

  • 4. Quantitative aspects of reversible osmotic opening of the blood-brain barrier.
    Rapoport SI, Fredericks WR, Ohno K, Pettigrew KD.
    Am J Physiol; 1980 May; 238(5):R421-31. PubMed ID: 7377381
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E, Gomori JM, Schwartz A, Lossos A, Bokstein F, Siegal T.
    Clin Pharmacol Ther; 2000 Jun 01; 67(6):631-41. PubMed ID: 10872645
    [Abstract] [Full Text] [Related]

  • 7. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
    Hiesiger EM, Voorhies RM, Basler GA, Lipschutz LE, Posner JB, Shapiro WR.
    Ann Neurol; 1986 Jan 01; 19(1):50-9. PubMed ID: 3080944
    [Abstract] [Full Text] [Related]

  • 8. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
    Pan GY, Liu XD, Liu GQ.
    Acta Pharmacol Sin; 2000 Jul 01; 21(7):613-6. PubMed ID: 11360668
    [Abstract] [Full Text] [Related]

  • 9. Lack of autoregulatory response of the cerebral circulation after osmotic opening of the blood-brain barrier in dogs.
    Koźniewska E, Skolasińska K.
    Acta Physiol Pol; 1980 Jul 01; 31(4):383-9. PubMed ID: 7446151
    [Abstract] [Full Text] [Related]

  • 10. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
    Spigelman MK, Zappulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF.
    Cancer Res; 1986 Mar 01; 46(3):1453-7. PubMed ID: 3510725
    [Abstract] [Full Text] [Related]

  • 11. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis.
    Kozler P, Pokorný J.
    Sb Lek; 2003 Mar 01; 104(3):255-62. PubMed ID: 15224531
    [Abstract] [Full Text] [Related]

  • 12. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
    Preston E, Slinn J, Vinokourov I, Stanimirovic D.
    J Neurosci Methods; 2008 Mar 15; 168(2):443-9. PubMed ID: 18155299
    [Abstract] [Full Text] [Related]

  • 13. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
    Neuwelt EA, Rapoport SI.
    Fed Proc; 1984 Feb 15; 43(2):214-9. PubMed ID: 6692941
    [Abstract] [Full Text] [Related]

  • 14. Cellular mechanisms of the blood-brain barrier (BBB) opening to albumin-gold complex.
    Vorbrodt AW, Lossinsky AS, Dobrogowska DH, Wisniewski HM.
    Histol Histopathol; 1993 Jan 15; 8(1):51-61. PubMed ID: 7680249
    [Abstract] [Full Text] [Related]

  • 15. Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate.
    Ennis SR, Betz AL.
    Invest Ophthalmol Vis Sci; 1986 Jul 15; 27(7):1095-102. PubMed ID: 3721787
    [Abstract] [Full Text] [Related]

  • 16. Bilirubin-induced changes in brain energy metabolism after osmotic opening of the blood-brain barrier.
    Wennberg RP, Johansson BB, Folbergrová J, Siesjö BK.
    Pediatr Res; 1991 Nov 15; 30(5):473-8. PubMed ID: 1754304
    [Abstract] [Full Text] [Related]

  • 17. Differential blood-brain barrier permeabilities to [14C]sucrose and [3H]inulin after osmotic opening in the rat.
    Ziylan YZ, Robinson PJ, Rapoport SI.
    Exp Neurol; 1983 Mar 15; 79(3):845-57. PubMed ID: 6825767
    [Abstract] [Full Text] [Related]

  • 18. Amphotericin B and the blood-brain barrier to methotrexate.
    Barry DI, Paulson OB.
    Neurosurgery; 1982 Feb 15; 10(2):224-6. PubMed ID: 7070618
    [Abstract] [Full Text] [Related]

  • 19. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
    Cosolo W, Christophidis N.
    Cancer Res; 1987 Dec 01; 47(23):6225-8. PubMed ID: 3119195
    [Abstract] [Full Text] [Related]

  • 20. Blood-brain barrier permeability to sucrose and dextran after osmotic opening.
    Ziylan YZ, Robinson PJ, Rapoport SI.
    Am J Physiol; 1984 Oct 01; 247(4 Pt 2):R634-8. PubMed ID: 6208789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.